companies / mynucleus-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 32,000,00032.0M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | New York, US | |
| industry | unknown | |
| stage | series-a |
Nucleus Genomics provides whole-genome screening, prenatal genetic services, and embryo selection analysis for IVF patients. It serves couples planning families and the 165+ fertility clinics that partner with the company globally. The platform extends beyond disease risk into polygenic trait scoring covering eye color, height, and cognitive measures.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-30 | series-a | 14,000,00014.0M | null | ○ |
| investor | src |
|---|---|
| Founders Fund | ○ |
Framer Sites, React 16.13.1, supabase, firebase
| fact | status | src |
|---|---|---|
| Series A, $14.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27latest_round: series-a, $14.0M, 2025-01-30, lead: founders-fund → series-a, $14.0M, 2025-01-30, lead: null, ○ 2026-05-08 | latest_round | series-a, $14.0M, 2025-01-30, lead: founders-fund → series-a, $14.0M, 2025-01-30, lead: null | ○ 2026-05-08 |
Records begin 2026-09-24. all_changes